ARA-290 (Cibinetide)
Also known as: ARA-290, Cibinetide, Innate repair receptor agonist
Molecular Overview
ARA-290 (cibinetide) is a peptide derived from the tissue-protective domain of erythropoietin that does not stimulate erythropoiesis, studied for the 'innate repair receptor' in tissue-protection research.
Mechanistic Background
Engages the innate repair receptor complex associated with tissue-protective signalling in experimental and some translational studies.
What Researchers Study
Research has examined tissue-protective and anti-inflammatory endpoints.
Evidence Landscape
Current evidence level: EARLY TRANSLATIONAL. Preclinical evidence does not equate to demonstrated human efficacy.
Research Limitations
Human data remain limited; much evidence is preclinical/early translational.
Scientific References
Research Use Only
Molecularix Biolabs provides research materials for legitimate laboratory research. Information in this Research Library is provided for educational and scientific reference purposes and is not medical advice, treatment guidance, or a recommendation for human or veterinary use.